- Home
- AVTX vs TVA Comparison
AVTX vs TVA Comparison
Compare AVTX & TVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$14.65
Company Overview
Basic Information| Metric | AVTX | TVA |
|---|---|---|
| Founded | 2011 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 328.4M | 315.3M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | AVTX | TVA |
|---|---|---|
| Price | $14.65 | $10.46 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $40.57 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 49.3K |
| Earning Date | 05-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 72.07 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,813,137.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2312.27 | N/A |
| 52 Week Low | $4.46 | $10.06 |
| 52 Week High | $24.27 | $12.27 |
Technical Indicators
Market Signals| Indicator | AVTX | TVA |
|---|---|---|
| Relative Strength Index (RSI) | 47.23 | 41.31 |
| Support Level | $13.22 | $10.41 |
| Resistance Level | $15.63 | $10.55 |
| Average True Range (ATR) | 0.93 | 0.03 |
| MACD | -0.16 | -0.01 |
| Stochastic Oscillator | 53.09 | 11.11 |
Price Performance
Historical Comparison AVTX
TVA
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
About TVA Texas Ventures Acquisition III Corp Class A Ordinary Share
Texas Ventures Acquisition III Corp is a blank check company.